Orkin S H
Department of Pediatrics, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115.
Cell. 1990 Nov 16;63(4):665-72. doi: 10.1016/0092-8674(90)90133-y.
Suggestions that the field of hemoglobin regulation and erythroid cell molecular biology was undergoing a tortuous and slow death, awash in the scientific community several years ago, were dispelled by the findings presented at the Seventh Conference on Hemoglobin Switching. After a phase in which neither the cis-elements nor trans-factors important for globin and erythroid gene expression were evident, recent progress has been rapid. Once again, studies in this area are providing fundamental insights into eukaryotic biology. The long-distance influence of LCR elements on chromatin structure and gene expression is remarkable and likely to be encountered in the analysis of other developmentally regulated, multigene loci. How LCR elements influence chromatin structure and maintain an open configuration is a problem at the core of gene regulation. We can be optimistic that further dissection of LCRs will delineate DNA sequences critical for these effects and associated proteins. The interaction of LCRs with individual genes must depend on specific protein-protein interactions, most likely involving a small, but elite, group of regulators. At least one critical transcriptional regulator of erythroid-expressed genes, GATA-1, is firmly established. Others are being pursued. The mechanisms by which they collaborate with each other should provide the missing pieces to the puzzle of cell-specific gene expression in the erythroid lineage. As the phenomenology of Hb switching is mimicked in transgenic mice, the elements mediating competitive and non-competitive (or autonomous) modes of regulation will be systematically delineated. Whether knowledge of the cis- and trans- components involved in switching will lead to the development of therapeutic approaches aimed at altering their complex interactions is uncertain. Fortunately, recent progress in hematopoietic stem cell biology once again raises hopes that gene transfer strategies for management of hemoglobin disorders may be more than a distant, impractical goal.
几年前,科学界曾流传着关于血红蛋白调控和红细胞分子生物学领域正经历着曲折且缓慢消亡的说法,但第七届血红蛋白转换会议上展示的研究结果驱散了这种论调。在经历了一段对珠蛋白和红细胞基因表达重要的顺式元件和反式因子均不明确的阶段后,近期进展迅速。该领域的研究再次为真核生物学提供了重要的见解。LCR元件对染色质结构和基因表达的远距离影响十分显著,很可能在分析其他发育调控的多基因位点时也会遇到。LCR元件如何影响染色质结构并维持开放构型是基因调控核心的一个问题。我们可以乐观地认为,对LCR的进一步剖析将明确对这些效应至关重要的DNA序列及相关蛋白质。LCR与单个基因的相互作用必定依赖于特定的蛋白质 - 蛋白质相互作用,很可能涉及一小群但极为关键的调节因子。至少一种对红细胞表达基因至关重要的转录调节因子GATA - 1已被明确证实。其他调节因子也正在研究中。它们相互协作的机制应能填补红细胞谱系中细胞特异性基因表达谜题中缺失的部分。随着转基因小鼠模拟了血红蛋白转换的现象学,介导竞争性和非竞争性(或自主性)调节模式的元件将被系统地描绘出来。参与转换的顺式和反式成分的知识是否会导致旨在改变其复杂相互作用的治疗方法的开发尚不确定。幸运的是,造血干细胞生物学的近期进展再次燃起了希望,即用于治疗血红蛋白疾病的基因转移策略可能不再是一个遥远、不切实际的目标。